US 8242112
Heterocyclic aspartyl protease inhibitors
granted A61PA61P25/00A61P25/28
Quick answer
US patent 8242112 (Heterocyclic aspartyl protease inhibitors) held by Pharmacopeia Drug Discovery, Inc. expires Mon Aug 09 2032 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.
Key facts
- Applicant
- Pharmacopeia Drug Discovery, Inc.
- Grant date
- Tue Aug 14 2012 00:00:00 GMT+0000 (Coordinated Universal Time)
- Expiration
- Mon Aug 09 2032 00:00:00 GMT+0000 (Coordinated Universal Time)
- Claims
- 4
- CPC classes
- A61P, A61P25/00, A61P25/28, A61P31/10, A61P31/18